| Cat.No. | Name | Information |
|---|---|---|
| M5252 | PRT-060318 | PRT-060318 (PRT318) is a novel selective inhibitor of the Syk tyrosine kinase, with IC50 of 4 nM. |
| M1767 | R-406 | R406 is an orally bioavailable and selective inhibitor of spleen tyrosine kinase (Syk) with the IC50 of 41nM and Ki value of 30 nM. |
| M49931 | Sovleplenib | Sovalleplenib is a potent, orally active, selective Syk inhibitor with an IC50 of 25 nM.Sovalleplenib inhibits tyrosine kinase-dependent Fcγ receptor-mediated phagocytosis by macrophages, which in turn reduces phagocytotic destruction of platelets, as well as reduces production of antiplatelet antibodies by B-cells.Sovalleplenib has antitumor activity in immune thrombocytopenia (ITP). |
| M20799 | GS-9876 (lanraplenib) | Lanraplenib (GS-9876, GS-SYK) is a potent, highly selective and orally active inhibitor of Spleen Tyrosine Kinase (SYK) with IC50 of 9.5 nM. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. |
| M20797 | SRX3207 | SRX3207 is a first-in-class, orally active Syk-PI3K inhibitor. |
| M14917 | Fostamatinib disodium hexahydrate | Fostamatinib (R788) disodium hexahydrate is the oral prodrug of the active compound R406. |
| M14916 | R406 besylate | R406 is an orally available and competitive Syk/FLT3 inhibitor for ATP binding with a Ki of 30 nM, potently inhibits Syk kinase activity in vitro with an IC50 of 41 nM, measured at an ATP concentration corresponding to its Km value. |
| M14915 | Cerdulatinib hydrochloride | Cerdulatinib hydrochloride (PRT062070) is a selective, oral active and reversible ATP-competitive inhibitor of dual SYK and JAK, with IC50s of 32 nM, 0.5 nM, 12 nM, 6 nM and 8 nM for SYK and Tyk2, JAK1, 2, 3, respectively. |
| M10688 | TAK-659 hydrochloride | TAK-659 hydrochloride is a highly selective, reversible, orally potent dual inhibitor of SYK/FLT3 that acts on SYK and FLT3 IC50 The values are 3.2 nM and 4.6 nM, respectively. TAK-659 hydrochloride induces tumor cell death without acting on non-tumor cells, with potential to study chronic lymphocytic leukemia (CLL). |
| M9012 | R112 | R112 is an ATP-competitive inhibitor of Syk kinase with an IC50 of 226 nM. |
| M5247 | BAY 61-3606 dihydrochloride | BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM). |
| M2941 | Piceatannol | Piceatannol, a natural stilbene, is a selective Syk inhibitor and ~10-fold selectivity versus Lyn. |
| M2729 | GS-9973 | GS-9973 is an orally bioavailable, selective Syk inhibitor with IC50 of 7.7 nM. |
| M2063 | P505-15 hydrochloride | P505-15 (PRT062607) is a novel, highly selective inhibitor of Syk with IC50 value of 1-2 nM. |
| M1990 | Fostamatinib | Fostamatinib (R788) is a spleen tyrosine kinase (Syk) inhibitor with IC50 of 41 nM. |
| M1847 | Fostamatinib disodium | Fostamatinib disodium (R788, R-935788) is a potent, ATP-competitive and selective Syk (Spleen tyrosine kinase) inhibitor with IC50 of 41 nM. |
| M57218 | GSK143 | GSK143 is an orally active and highly selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.5. |
| M57217 | PRT062607 | PRT062607(P505-15; PRT-2607; BIIB-057) is a highly specific and potent inhibitor of Syk with IC50 of 1-2 nM; >80-fold selective for Syk than Fgr, Lyn, FAK, Pyk2 and Zap70. |
| M57216 | GSK143 dihydrochloride | GSK143 dihydrochloride is an orally active and highly selective spleen tyrosine kinase (SYK) inhibitor with a pIC50 of 7.5. |
| M50405 | Syk Kinase Peptide Substrate | Syk Kinase Peptide Substrate is a Syk kinase peptide substrate. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
